메뉴 건너뛰기




Volumn 86, Issue 2, 2016, Pages 184-189

In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates

Author keywords

Acinetobacter baumannnii; Colistin; Combination; Meropenem; Rifampicin; Synergism

Indexed keywords

CARBAPENEM DERIVATIVE; COLISTIN; DOXYCYCLINE; IMIPENEM; MEROPENEM; RIFAMPICIN; TIGECYCLINE; ANTIINFECTIVE AGENT;

EID: 84989850702     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.07.017     Document Type: Article
Times cited : (28)

References (28)
  • 1
    • 84899750775 scopus 로고    scopus 로고
    • Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter Baumannii
    • Al-Shaer, M, Nazer, LH, Kherallah, M, Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter Baumannii. Ann Pharmacother 48:6 (2014), 766–771.
    • (2014) Ann Pharmacother , vol.48 , Issue.6 , pp. 766-771
    • Al-Shaer, M.1    Nazer, L.H.2    Kherallah, M.3
  • 2
    • 57749107808 scopus 로고    scopus 로고
    • Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
    • Boucher, HW, Talbot, GH, Bradley, JS, Edwards, JE, Gilbert, D, Rice, LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1 (2009), 1–12.
    • (2009) Clin Infect Dis , vol.48 , Issue.1 , pp. 1-12
    • Boucher, H.W.1    Talbot, G.H.2    Bradley, J.S.3    Edwards, J.E.4    Gilbert, D.5    Rice, L.B.6
  • 3
    • 84964945443 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing; 26th informational supplement; M100-S26
    • CLSI Wayne, PA
    • Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing; 26th informational supplement; M100-S26. 2016, CLSI, Wayne, PA.
    • (2016)
  • 4
    • 17644389620 scopus 로고    scopus 로고
    • Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
    • Falagas, ME, Kasiakou, SK, Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:9 (2005), 1333–1341.
    • (2005) Clin Infect Dis , vol.40 , Issue.9 , pp. 1333-1341
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 5
    • 34447560960 scopus 로고    scopus 로고
    • Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
    • Falagas, ME, Kasiakou, SK, Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care, 10(1), 2006, R27.
    • (2006) Crit Care , vol.10 , Issue.1 , pp. R27
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 6
    • 33644787044 scopus 로고    scopus 로고
    • Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)
    • Gales, AC, Jones, RN, Sader, HS, Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 12:4 (2006), 315–321.
    • (2006) Clin Microbiol Infect , vol.12 , Issue.4 , pp. 315-321
    • Gales, A.C.1    Jones, R.N.2    Sader, H.S.3
  • 7
    • 40549129995 scopus 로고    scopus 로고
    • ReAct-action on antibiotic R clinical and economic impact of common multidrug-resistant gram-negative bacilli
    • Giske, CG, Monnet, DL, Cars, O, Carmeli, Y, ReAct-action on antibiotic R clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52:3 (2008), 813–821.
    • (2008) Antimicrob Agents Chemother , vol.52 , Issue.3 , pp. 813-821
    • Giske, C.G.1    Monnet, D.L.2    Cars, O.3    Carmeli, Y.4
  • 8
    • 84888230326 scopus 로고    scopus 로고
    • In vitro synergistic activity of colistin with tigecycline or beta-lactam antibiotic/beta-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter Baumannii
    • Karaoglan, I, Zer, Y, Bosnak, VK, Mete, AO, Namiduru, M, In vitro synergistic activity of colistin with tigecycline or beta-lactam antibiotic/beta-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter Baumannii. J Int Med Res 41:6 (2013), 1830–1837.
    • (2013) J Int Med Res , vol.41 , Issue.6 , pp. 1830-1837
    • Karaoglan, I.1    Zer, Y.2    Bosnak, V.K.3    Mete, A.O.4    Namiduru, M.5
  • 9
    • 84931093650 scopus 로고    scopus 로고
    • In vivo selection of pan-drug resistant Acinetobacter Baumannii during antibiotic treatment
    • Kim, Y, Bae, IK, Jeong, SH, Yong, D, Lee, K, In vivo selection of pan-drug resistant Acinetobacter Baumannii during antibiotic treatment. Yonsei Med J 56:4 (2015), 928–934.
    • (2015) Yonsei Med J , vol.56 , Issue.4 , pp. 928-934
    • Kim, Y.1    Bae, I.K.2    Jeong, S.H.3    Yong, D.4    Lee, K.5
  • 10
    • 84902073922 scopus 로고    scopus 로고
    • In vivo emergence of colistin resistance in Acinetobacter Baumannii clinical isolates of sequence type 357 during colistin treatment
    • Kim, Y, Bae, IK, Lee, H, Jeong, SH, Yong, D, Lee, K, In vivo emergence of colistin resistance in Acinetobacter Baumannii clinical isolates of sequence type 357 during colistin treatment. Diagn Microbiol Infect Dis 79:3 (2014), 362–366.
    • (2014) Diagn Microbiol Infect Dis , vol.79 , Issue.3 , pp. 362-366
    • Kim, Y.1    Bae, I.K.2    Lee, H.3    Jeong, S.H.4    Yong, D.5    Lee, K.6
  • 11
    • 84880260396 scopus 로고    scopus 로고
    • Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter Baumannii in an in vitro pharmacokinetic/pharmacodynamic model
    • Lee, HJ, Bergen, PJ, Bulitta, JB, Tsuji, B, Forrest, A, Nation, RL, et al. Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter Baumannii in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 57:8 (2013), 3738–3745.
    • (2013) Antimicrob Agents Chemother , vol.57 , Issue.8 , pp. 3738-3745
    • Lee, H.J.1    Bergen, P.J.2    Bulitta, J.B.3    Tsuji, B.4    Forrest, A.5    Nation, R.L.6
  • 12
    • 33747362870 scopus 로고    scopus 로고
    • Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections
    • Li, J, Nation, RL, Turnidge, JD, Milne, RW, Coulthard, K, Rayner, CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis 6:9 (2006), 589–601.
    • (2006) Lancet Infect Dis , vol.6 , Issue.9 , pp. 589-601
    • Li, J.1    Nation, R.L.2    Turnidge, J.D.3    Milne, R.W.4    Coulthard, K.5    Rayner, C.R.6
  • 13
    • 0034081239 scopus 로고    scopus 로고
    • Comparison of methods for assessing synergic antibiotic interactions
    • Mackay, ML, Milne, K, Gould, IM, Comparison of methods for assessing synergic antibiotic interactions. Int J Antimicrob Agents 15:2 (2000), 125–129.
    • (2000) Int J Antimicrob Agents , vol.15 , Issue.2 , pp. 125-129
    • Mackay, M.L.1    Milne, K.2    Gould, I.M.3
  • 14
    • 84903384235 scopus 로고    scopus 로고
    • Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing gram-negative bacteria
    • Nastro, M, Rodriguez, CH, Monge, R, Zintgraff, J, Neira, L, Rebollo, M, et al. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing gram-negative bacteria. J Chemother 26:4 (2014), 211–216.
    • (2014) J Chemother , vol.26 , Issue.4 , pp. 211-216
    • Nastro, M.1    Rodriguez, C.H.2    Monge, R.3    Zintgraff, J.4    Neira, L.5    Rebollo, M.6
  • 15
    • 79960345860 scopus 로고    scopus 로고
    • Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae
    • Pankey, GA, Ashcraft, DS, Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis 70:4 (2011), 561–564.
    • (2011) Diagn Microbiol Infect Dis , vol.70 , Issue.4 , pp. 561-564
    • Pankey, G.A.1    Ashcraft, D.S.2
  • 16
    • 84885390856 scopus 로고    scopus 로고
    • Comparison of 3 Etest((R)) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species
    • Pankey, GA, Ashcraft, DS, Dornelles, A, Comparison of 3 Etest((R)) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species. Diagn Microbiol Infect Dis 77:3 (2013), 220–226.
    • (2013) Diagn Microbiol Infect Dis , vol.77 , Issue.3 , pp. 220-226
    • Pankey, G.A.1    Ashcraft, D.S.2    Dornelles, A.3
  • 17
    • 84863115478 scopus 로고    scopus 로고
    • In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter Baumannii, including colistin- or tigecycline-resistant isolates
    • Peck, KR, Kim, MJ, Choi, JY, Kim, HS, Kang, CI, Cho, YK, et al. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter Baumannii, including colistin- or tigecycline-resistant isolates. J Med Microbiol 61:Pt 3 (2012), 353–360.
    • (2012) J Med Microbiol , vol.61 , pp. 353-360
    • Peck, K.R.1    Kim, M.J.2    Choi, J.Y.3    Kim, H.S.4    Kang, C.I.5    Cho, Y.K.6
  • 19
    • 84884568940 scopus 로고    scopus 로고
    • In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter Baumannii: possible options for the treatment of complicated infection
    • Principe, L, Capone, A, Mazzarelli, A, D'Arezzo, S, Bordi, E, Di Caro, A, et al. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter Baumannii: possible options for the treatment of complicated infection. Microb Drug Resist 19:5 (2013), 407–414.
    • (2013) Microb Drug Resist , vol.19 , Issue.5 , pp. 407-414
    • Principe, L.1    Capone, A.2    Mazzarelli, A.3    D'Arezzo, S.4    Bordi, E.5    Di Caro, A.6
  • 20
    • 84859579184 scopus 로고    scopus 로고
    • Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary gram-negative pathogens in New York City
    • Quale, J, Shah, N, Kelly, P, Babu, E, Backer, M, Rosas-Garcia, G, et al. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary gram-negative pathogens in New York City. Microb Drug Resist 18:2 (2012), 132–136.
    • (2012) Microb Drug Resist , vol.18 , Issue.2 , pp. 132-136
    • Quale, J.1    Shah, N.2    Kelly, P.3    Babu, E.4    Backer, M.5    Rosas-Garcia, G.6
  • 22
    • 70049083489 scopus 로고    scopus 로고
    • Selection of colistin-resistant Acinetobacter Baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin
    • Rodriguez, CH, Bombicino, K, Granados, G, Nastro, M, Vay, C, Famiglietti, A, Selection of colistin-resistant Acinetobacter Baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis 65:2 (2009), 188–191.
    • (2009) Diagn Microbiol Infect Dis , vol.65 , Issue.2 , pp. 188-191
    • Rodriguez, C.H.1    Bombicino, K.2    Granados, G.3    Nastro, M.4    Vay, C.5    Famiglietti, A.6
  • 23
    • 77951175059 scopus 로고    scopus 로고
    • In vitro antimicrobials activity against endemic Acinetobacter Baumannii multiresistant clones
    • Rodriguez, CH, De Ambrosio, A, Bajuk, M, Spinozzi, M, Nastro, M, Bombicino, K, et al. In vitro antimicrobials activity against endemic Acinetobacter Baumannii multiresistant clones. J Infect Dev Ctries 4:3 (2010), 164–167.
    • (2010) J Infect Dev Ctries , vol.4 , Issue.3 , pp. 164-167
    • Rodriguez, C.H.1    De Ambrosio, A.2    Bajuk, M.3    Spinozzi, M.4    Nastro, M.5    Bombicino, K.6
  • 24
    • 84863654489 scopus 로고    scopus 로고
    • Combination therapy for treatment of infections with gram-negative bacteria
    • Tamma, PD, Cosgrove, SE, Maragakis, LL, Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25:3 (2012), 450–470.
    • (2012) Clin Microbiol Rev , vol.25 , Issue.3 , pp. 450-470
    • Tamma, P.D.1    Cosgrove, S.E.2    Maragakis, L.L.3
  • 25
    • 0029134774 scopus 로고
    • Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing
    • Tenover, FC, Arbeit, RD, Goering, RV, Mickelsen, PA, Murray, BE, Persing, DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:9 (1995), 2233–2239.
    • (1995) J Clin Microbiol , vol.33 , Issue.9 , pp. 2233-2239
    • Tenover, F.C.1    Arbeit, R.D.2    Goering, R.V.3    Mickelsen, P.A.4    Murray, B.E.5    Persing, D.H.6
  • 26
    • 84899999628 scopus 로고    scopus 로고
    • In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter Baumannii by checkerboard method
    • Thamlikitkul, V, Tiengrim, S, In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter Baumannii by checkerboard method. J Med Assoc Thai 97:Suppl. 3 (2014), S1–S6.
    • (2014) J Med Assoc Thai , vol.97 , pp. S1-S6
    • Thamlikitkul, V.1    Tiengrim, S.2
  • 27
    • 0037613601 scopus 로고    scopus 로고
    • Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes
    • Wiese, A, Gutsmann, T, Seydel, U, Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. J Endotoxin Res 9:2 (2003), 67–84.
    • (2003) J Endotoxin Res , vol.9 , Issue.2 , pp. 67-84
    • Wiese, A.1    Gutsmann, T.2    Seydel, U.3
  • 28
    • 84888056665 scopus 로고    scopus 로고
    • Combination therapy for carbapenem-resistant gram-negative bacteria
    • Zavascki, AP, Bulitta, JB, Landersdorfer, CB, Combination therapy for carbapenem-resistant gram-negative bacteria. Expert Rev Anti Infect Ther 11:12 (2013), 1333–1353.
    • (2013) Expert Rev Anti Infect Ther , vol.11 , Issue.12 , pp. 1333-1353
    • Zavascki, A.P.1    Bulitta, J.B.2    Landersdorfer, C.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.